JB Chemicals & Pharmaceuticals Q1 Results FY26: Q1 PAT Rose 14.45% to ₹202.38 Crore; Revenue Surged 8.91% YoY

JB Chemicals & Pharmaceuticals Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹1,093.94	₹1,004.40
Profit Before Tax (PBT)	₹315.42	₹286.26
Profit After Tax (PAT)	₹202.38	₹176.83

(Figures in crores)

JB Chemicals & Pharmaceuticals Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹1,039.90	₹952.31
Profit Before Tax (PBT)	₹307.02	₹278.54
Profit After Tax (PAT)	₹197.87	₹173.23

(Figures in crores)

JB Chemicals & Pharmaceuticals Results FY26 Highlights (Q1 FY26 vs FY25)

• JB Chemicals & Pharmaceuticals clocked Q1 FY26 consolidated revenue of ₹1,093.94 crores vs ₹1,004.40 crores. 
• On the profit front, JB Chemicals & Pharmaceuticals earned a consolidated PAT of ₹202.38 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹176.83 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 14.45% YoY, and revenue rose 8.91% YoY. 
• As per the standalone figures, the quarterly PAT of JB Chemicals & Pharmaceuticals has increased by 14.22%, and revenue has increased by 9.20% YoY.

JB Chemicals & Pharmaceuticals Share Price Performance

On the opening bell of 31st July 2025, the shares of JB Chemicals & Pharmaceuticals opened at ₹1768.90 per share. However, the initial gains are wiped out as of now, and JB Chemicals & Pharmaceuticals shares are trading at ₹1765.10 per share, lower than their opening price. 

Considering the long-term performance, JB Chemicals & Pharmaceuticals shares have yielded returns of approximately 9.29% over the past year, and 5-year returns stand at 384.99%. Over the maximum timeframe, the JB Chemicals & Pharmaceuticals share provided investors with returns of 4,390.18 %. However, one must ignore the risk of volatility in the stock market and invest in JB Chemicals & Pharmaceuticals shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Shriram Finance Q1 Results FY26: Q1 PAT Rose 6.75% to ₹2,159.4 Crore; Revenue Surged 20.11% YoY

Recent Articles

Flysbs Aviation IPO GMP & Review: Apply or Avoid?

New India Assurance Company Q1 Results FY26: Q1 PAT Surged 67.29% to ₹400.33 Crore; Revenue Soared 10.26% YoY

Sri Lotus Developers IPO GMP: Day 1 IPO Live Updates

Varun Beverages Q1 Results FY26: Q1 PAT Surged 5.14% to ₹1,317.02 Crore; Revenue Dropped 2.33% YoY

Takyon Networks IPO GMP: Day 1 IPO Live Updates

Asian Paints Q1 Results FY26: Q1 PAT Plunged 6.00% to ₹1,099.77 Crore; Revenue Dropped 0.35% YoY